<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-147312</identifier>
<setSpec>1699-258X</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">The complement system in the pathogenesis of antineutrophil cytoplasm antibodies-associated vasculitis</dc:title>
<dc:description xml:lang="en">One of the main characteristics of the vasculitis associated with antineutrophil cytoplasm autoantibodies (AASV) is the absence of immune complex deposition in biopsies of affected tissues as well as a lack of complement depletion. However, in early stages of disease induced in animal models, it has been observed that the complement system may be involved in the generation of these diseases. There are various animal models which have been developed with the aim of knowing which are the pathogenic mechanisms in granulomatosis with polyangiitis (Wegener) (GPA) and microscopic polyangiitis (MPA), the latter being explained using these approaches in a more satisfactory manner, as there is lack of a model which reproduces the changes leading to a granulomatous vasculitis associated with antibodies against proteinase-3, as in GPA. This short review presents recent evidence of the presence of complement in biopsies of patients with AASV and the most recent animal models, which show the participation of complement in their etiology (AU)</dc:description>
<dc:creator>Flores-Suárez, Luis F</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">Una de las características principales de las vasculitis asociadas a ANCA (VAA) es la ausencia de depósito de complejos inmunes en las biopsias de los tejidos afectados y de consumo de complemento. Sin embargo, en etapas tempranas de enfermedades similares producidas en modelos animales, se ha observado que el sistema del complemento puede participar en la génesis de estas patologías. Varios modelos se han desarrollado en el intento de disecar los mecanismos patogénicos de enfermedades como granulomatosis con poliangitis (Wegener) (GPA) o poliangitis microscópica siendo más exitosos en esta última, sin que hasta el momento se disponga de un modelo satisfactorio para explicar los cambios que llevan a enfermedad granulomatosa vasculítica, máxime si se asocia a anticuerpos contra proteinasa-3 (PR-3), como es el caso en la GPA. Este manuscrito revisa en forma sucinta las evidencias recientes de la presencia de complemento en biopsias de pacientes con VAA, así como modelos animales que ponen de manifiesto la participación del sistema de complemento en su patogenia (AU)</dc:description>
<dc:source>Reumatol. clín. (Barc.);7(supl.3): s18-s21, dic. 2011. tab</dc:source>
<dc:identifier>ibc-147312</dc:identifier>
<dc:title xml:lang="es">El sistema del complemento en la patogenia de las vasculitis asociadas a anticuerpos anticitoplasma de neutrófilo</dc:title>
<dc:subject>^d29611</dc:subject>
<dc:subject>^d8994</dc:subject>
<dc:subject>^d53544^s22038</dc:subject>
<dc:subject>^d53545^s22038</dc:subject>
<dc:subject>^d8999</dc:subject>
<dc:subject>^d7840^s22053</dc:subject>
<dc:subject>^d31878^s22038</dc:subject>
<dc:subject>^d27929^s22038</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d3206</dc:subject>
<dc:subject>^d7840^s22038</dc:subject>
<dc:subject>^d22132^s22038</dc:subject>
<dc:subject>^d4313^s22015</dc:subject>
<dc:subject>^d841</dc:subject>
<dc:subject>^d1731</dc:subject>
<dc:subject>^d24580^s22006</dc:subject>
<dc:subject>^d33077^s22002</dc:subject>
<dc:subject>^d920^s22073</dc:subject>
<dc:subject>^d1330^s22038</dc:subject>
<dc:subject>^d33077^s22038</dc:subject>
<dc:subject>^d52245^s22038</dc:subject>
<dc:subject>^d22137^s22006</dc:subject>
<dc:type>article</dc:type>
<dc:date>201112</dc:date>
</metadata>
</record>
</ibecs-document>
